Sale!

VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test

Original price was: $700.Current price is: $500.

-29%

The VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test is a comprehensive genetic screening that detects mutations in the VHL gene associated with von Hippel-Lindau syndrome, a rare inherited disorder that significantly increases cancer risk. This advanced next-generation sequencing test provides crucial information about hereditary cancer predisposition, enabling early detection and proactive management strategies. The test is particularly important for individuals with family history of VHL syndrome or those experiencing related symptoms. At only $500 USD, this test offers invaluable insights into genetic cancer risks, helping patients and healthcare providers develop personalized surveillance and prevention plans. Early identification of VHL gene mutations can lead to timely interventions and improved health outcomes.

Clinically Validated & Lab Certified

  • ISO-Accredited Laboratory, Ensuring Highest Standards
  • Trusted by Hospitals & Patients —Accredited Testing with Results
  • Direct Healthcare Provider Support + Comprehensive Reporting
Guaranteed Safe Checkout

VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test

Comprehensive Genetic Testing for Hereditary Cancer Risk

The VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test represents a cutting-edge approach to identifying individuals at risk for von Hippel-Lindau syndrome, a rare autosomal dominant genetic disorder that predisposes affected individuals to multiple tumor types. This sophisticated genetic analysis utilizes next-generation sequencing technology to provide comprehensive screening of the VHL gene, offering crucial insights into hereditary cancer predisposition and enabling proactive healthcare management.

What Does This Test Measure and Detect?

This advanced genetic test specifically targets the VHL (von Hippel-Lindau) tumor suppressor gene, which plays a critical role in regulating cell growth and preventing tumor formation. The test detects:

  • Pathogenic mutations in the VHL gene associated with von Hippel-Lindau syndrome
  • Various types of genetic alterations including point mutations, deletions, and insertions
  • Germline mutations that can be inherited across generations
  • Specific genetic variants linked to different manifestations of VHL syndrome

Who Should Consider This Genetic Test?

This test is particularly recommended for individuals who present with:

  • Personal history of hemangioblastomas in the brain, spinal cord, or retina
  • Diagnosis of renal cell carcinoma, especially at a young age
  • Pheochromocytomas or pancreatic neuroendocrine tumors
  • Endolymphatic sac tumors or epididymal cystadenomas
  • Family history of von Hippel-Lindau syndrome
  • Multiple benign or malignant tumors in various organs
  • Unexplained vision problems or neurological symptoms

Significant Benefits of VHL Genetic Testing

Undergoing VHL genetic testing provides numerous advantages for patients and their families:

  • Early Risk Assessment: Identify genetic predisposition before symptoms develop
  • Personalized Surveillance: Implement targeted screening protocols based on genetic status
  • Family Planning Guidance: Make informed reproductive decisions with genetic counseling
  • Proactive Management: Initiate early interventions to prevent complications
  • Psychological Relief: Reduce uncertainty through definitive genetic information
  • Improved Outcomes: Enable timely detection and treatment of associated conditions

Understanding Your Test Results

Your VHL genetic test results will fall into one of several categories:

  • Positive Result: Indicates the presence of a pathogenic VHL mutation, confirming von Hippel-Lindau syndrome diagnosis and necessitating comprehensive medical management
  • Negative Result: No VHL mutation detected, significantly reducing but not completely eliminating VHL syndrome risk
  • Variant of Uncertain Significance: Identifies a genetic change with unknown clinical significance, requiring ongoing monitoring and research
  • No Mutation Detected: In individuals with clinical VHL features, may indicate technical limitations or mutations in other genes

Test Pricing Information

Test Description Price (USD)
VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test – Discount Price $500
VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test – Regular Price $700

Comprehensive Testing Process

Our VHL genetic testing follows a meticulous process to ensure accuracy and reliability:

  • Sample Collection: Blood sample, extracted DNA, or one drop of blood on FTA card
  • Turnaround Time: 3 to 4 weeks for comprehensive analysis and reporting
  • Pre-test Requirements: Complete clinical history and genetic counseling session
  • Family Pedigree: Detailed family history documentation of affected relatives
  • Expert Analysis: Interpretation by board-certified genetic specialists

Nationwide Accessibility

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many other cities. Our extensive network ensures that comprehensive genetic testing is accessible to patients nationwide.

Take Control of Your Genetic Health Today

Don’t wait to understand your genetic cancer risk. Our VHL Gene von Hippel-Lindau Syndrome NGS Genetic DNA Test provides the critical information needed for proactive health management. With advanced NGS technology and expert genetic counseling, you can make informed decisions about your healthcare journey.

Call or WhatsApp us today at +1(267) 388-9828 to schedule your genetic counseling session and book your VHL genetic test. Our dedicated genetic specialists are ready to guide you through the testing process and help you understand your results.